Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Antengene Corporation Limited ( (HK:6996) ) has shared an announcement.
Antengene Corporation Limited has announced its upcoming annual general meeting (AGM) to be held on June 13, 2025, both online and physically in Shanghai, China. The AGM will address several key resolutions, including the approval of the company’s financial statements for 2024, the re-election of directors, the re-appointment of Ernst & Young as auditors, and the authorization for directors to manage share allotments. These resolutions are crucial for Antengene’s governance and operational strategies, potentially impacting its market positioning and stakeholder relationships.
More about Antengene Corporation Limited
Antengene Corporation Limited is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative oncology therapies. The company operates in the healthcare industry, emphasizing the treatment of cancer and related diseases.
YTD Price Performance: 387.50%
Technical Sentiment Signal: Sell
Current Market Cap: €214.7M
Learn more about 6996 stock on TipRanks’ Stock Analysis page.